Innate Pharma, Inc
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$3.3M
Doctors Paid
135
Transactions
299
2021 Total
$172,701
Payment Breakdown by Category
Research$3.3M (97.8%)
Consulting$29,136 (0.9%)
Food & Beverage$3,464 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $3.3M | 170 | 97.8% |
| Honoraria | $39,750 | 20 | 1.2% |
| Consulting Fee | $29,136 | 9 | 0.9% |
| Food and Beverage | $3,464 | 100 | 0.1% |
Payments by Type
Research
$3.3M
170 transactions
General
$72,350
129 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| Study of IPH2201 (Monalizumab) and Cetuximab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck | $2.2M | 0 | 88 |
| An Open Label, Multicohort, Multi-center Phase II Study Evaluating the Efficacy and Safety of IPH4102/Lacutamab Alone or in Combination With Chemotherapy in Patients With Advanced T-cell Lymphoma | $440,121 | 1 | 24 |
| A Phase I Study of Moxetumomab Pasudotox-tdfk (Lumoxiti) and Rituximab (Rituxan) for Relapsed Hairy Cell Leukemia | $212,080 | 0 | 2 |
| A Phase I Study of the Anti-C5aR, Avdoralimab (IPH5401), in Combination With the Anti-PD-L1, Durvalumab, in Patients With Selected Advanced Solid Tumors | $155,954 | 0 | 23 |
| A phase-I study of the anti-C5aR, IPH5401, in combination with the anti-PDL-1, durvalumab, in patients with selected advanced solid tumors | $150,989 | 6 | 20 |
| Open Label, Multicenter Phase I Study of IPH4102, a Humanized Anti-KIR3DL2 Monoclonal Antibody, in Patients With Relapsed/Refractory Cutaneous T-cell Lymphomas (CTCL) | $129,531 | 0 | 13 |
Payments by Medical Specialty
| Specialty | Total Paid | Doctors | Avg/Doctor |
|---|---|---|---|
| Medical Oncology | $140,001 | 19 | $7,368 |
| Hematology & Oncology | $40,770 | 72 | $566.25 |
| Internal Medicine | $21,440 | 18 | $1,191 |
| Dermatopathology | $14,848 | 1 | $14,848 |
| Hematology | $11,868 | 13 | $912.91 |
| Specialist | $1,268 | 6 | $211.30 |
| Dermatology | $483.33 | 1 | $483.33 |
| Hospice and Palliative Medicine | $36.91 | 2 | $18.46 |
| Gynecologic Oncology | $19.03 | 1 | $19.03 |
| Pediatrics | $12.35 | 1 | $12.35 |
Top Paid Doctors — Page 2
| Doctor | Specialty | Location | Total | 2020 |
|---|---|---|---|---|
| Matthew Whitehurst, Md, MD | Internal Medicine | Fredericksburg, VA | $1,200 | $0 |
| Dr. Mihran Shirinian, M.d, M.D | Hematology & Oncology | Glendale, CA | $1,200 | $0 |
| Sanjeev Jain, Md, MD | Hematology & Oncology | East Patchogue, NY | $1,200 | $0 |
| Dr. Charanjeev Kapoor, M.d, M.D | Specialist | Manchester, CT | $1,200 | $0 |
| Dr. Xylina Gregg, M.d, M.D | Hematology & Oncology | Salt Lake City, UT | $1,200 | $0 |
| Hassan Ghazal, Md, MD | Hematology & Oncology | Hazard, KY | $1,200 | $0 |
| Leslie Oleksowicz, M.d, M.D | Internal Medicine | Cincinnati, OH | $550.00 | $0 |
| Dr. Oleg Akilov, M.d., Ph.d, M.D., PH.D | Dermatology | Pittsburgh, PA | $483.33 | $0 |
| Nam Dang, Md, MD | Hematology & Oncology | Gainesville, FL | $358.33 | $0 |
| Dr. Eric Jacobsen, Md, MD | Hematology & Oncology | Boston, MA | $340.00 | $0 |
| Dr. Catherine Coombs, M.d, M.D | Hematology & Oncology | Orange, CA | $250.00 | $0 |
| Dr. Marc Nuttall, Md, MD | Internal Medicine | Provo, UT | $33.42 | $0 |
| Dr. T Singh, M.d, M.D | Hematology & Oncology | Flint, MI | $29.11 | $0 |
| Dr. David Eilender, Md, MD | Hematology & Oncology | Soldotna, AK | $29.11 | $0 |
| Dr. Madan Arora, M.d, M.D | Hematology & Oncology | Flint, MI | $29.11 | $0 |
| Dr. Sharon Cole, M.d, M.D | Hematology & Oncology | Findlay, OH | $26.57 | $0 |
| Tracy Dobbs, Md, MD | Hematology & Oncology | Knoxville, TN | $26.01 | $0 |
| Rambabu Tummala, Md, MD | Medical Oncology | Leesburg, FL | $24.21 | $0 |
| Dr. Paul Gonter, M.d, M.D | Hematology | Venice, FL | $23.85 | $0 |
| Dr. Andres Soriano, M.d, M.D | Hematology | North Venice, FL | $23.85 | $0 |
| Dr. Charles Maurer, Md, MD | Hematology & Oncology | Fredericksburg, VA | $22.39 | $0 |
| M Ashraf Meelu, Md, MD | Hematology & Oncology | Waldorf, MD | $22.16 | $0 |
| Dr. Gregory Chipman, M.d, M.D | Hematology & Oncology | American Fork, UT | $21.31 | $0 |
| Dr. Bret Cook, Md, MD | Hematology & Oncology | Coos Bay, OR | $21.00 | $0 |
| Dr. Labib Hashimi, M.d, M.D | Hematology | Chino, CA | $20.94 | $0 |
About Innate Pharma, Inc
Innate Pharma, Inc has made $3.3M in payments to 135 healthcare providers, recorded across 299 transactions in the CMS Open Payments database. In 2021, the company paid $172,701. The top product by payment volume is Lumoxiti ($435,419).
Payments were distributed across 10 medical specialties. The top specialty by payment amount is Medical Oncology ($140,001 to 19 doctors).
Payment categories include: Food & Beverage ($3,464), Consulting ($29,136), Research ($3.3M).
Innate Pharma, Inc is associated with 1 products in the CMS Open Payments database.